Zhiping Guo

1PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 07, 2025
Potential Off-Target Effect of Gilteritinib With Venetoclax Decreases Tumor Burden for Patients With Relapsed/Refractory Wild-Type FLT3 Acute Myeloid Leukemia/Myelodysplastic Neoplasms.

Shuting Chang, Zhijuan Pan, Yiqun Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Shuting Chang

1 joint publications

Xinlei Guo